oppn parties Sub-Standard Drugs: India Must Take Strict Action

News Snippets

  • Delhi chief minister Arvind Kejriwal, referring to a spate of FIRs for putting up posters in Delhi which said "Modi Hatao, Desh Bachao", said that even the British did not act in such manner
  • The 2023-24 Appropriation BIll, which allows the government to spend Rs 45 lakh crore in the fiscal, was passed by Lok Sabha in 9 minutes without any discussion
  • Sources say that Amritpal Singh fled to Haryana and may now be in Uttarakhand
  • Experts say that Rahul Gandhi's disqualification from Parliament will kick in immediately as the conviction has not been stayed
  • Tatas to invest $2bn in super app Tata Neu
  • Chief Economic Advisor V Anantha Nageswaran has said that inflation will drop as commodity and food prices have fallen
  • Government will define quality norms to ensure better 5G service
  • Stocks tumble again on Thursday after two sessions of recovery: Sensex loses 289 points to 57925 and Nifty goes down by 75 points to 17076
  • Amicus curiae and senior advocate K V Vishwanathan has told the Supreme Court that the changes made in law and three extensions given to the present director of Enforcement Directorate are illegal and will imperil the integrity of the agency
  • Supreme Court says it cannot judicially direct the government to acquire land or buildings near the court for advocates' chambers
  • ISSF Cup shooting: Indian pair of Rhythm Sangwan and Varun Tomar win silver in 10m sir rifle mixed team event
  • WPL: UP Warriorz take on Mumbai Indians in the Eliminator today. The winner will play Delhi Capitals in the finals
  • World Boxing: Four Indians - Nikhat Zareen, Nitu Ghanghas, Lovelina Borgohain and Saweety Boora - enter the frinals in their respective category
  • Bombay HC imposes costs and dismisses a petition by a housing society that sought to have a community-wise cap on residents
  • Delhi Police files 159 FIRs for defacement of public property and 49 for posters saying 'Modi Hatao Desh Bachao'
Rahul Gandhi disqualified from Parliament, Wayanad Lok Sabha seat declared vacant
oppn parties
Sub-Standard Drugs: India Must Take Strict Action

By Sunil Garodia
First publised on 2022-12-31 07:54:11

About the Author

Sunil Garodia Editor-in-Chief of indiacommentary.com. Current Affairs analyst and political commentator.

The position of India as the pharmacy of the world (for supplying generic medicines at low cost) is in danger after two successive incidents of supply of allegedly sub-standard and/or spurious products. Close on the heels of ruckus raised by the death of more than 66 children in Gambia (which was allegedly flagged by WHO without proper preliminary inquiry) by drinking paediatric cough syrups made in India by Haryana-based Maiden Pharmaceuticals which allegedly deed not meet the prescribed standards (an inquiry by the Indian government exonerated the manufacturer of any wrongdoing) comes the allegation from Uzbekistan that many children have died there after consuming cough syrups made and supplied by Noida-based Marion Biotech Private Limited. Drug regulators in India have asked the firm to stop production pending an investigation.

Even though nothing has been heard further about the Gambia case (although one is sure that the Central government is taking it up in all forums), this new case complicates matter further. In addition, data from Central Drugs Standard Control Organization (CDSCO) shows that out of 1487 samples picked up by regulatory agencies from drug manufacturers' facilities across India, 83 or 6% were found to be sub-standard. Greed, and the desire to make extra profits, leads some dirty fish among drug manufacturers to use sub-standard material or play around with accepted formulas to endanger lives. This cannot be allowed. Manufacturers have to adhere to good manufacturing practises (GMP) and ensure that no sub-standard product leaves their manufacturing facilities.

The Indian Pharmaceuticals Alliance and the Central and state governments have a huge role in ensuring this. There should be mandatory random checks of export consignments (in addition to periodic checks at manufacturing facilities). Drug manufacturers and the government have to all to ensure that India pharmaceuticals products meet accepted world standards and there is no deviation to maintain India's place as the prominent drug supplier in the world. Drug manufacturers found indulging in cutting corners should be punished as per law and their licences should be cancelled even if one wilful deviation is detected and the promoters should be blacklisted and denied licence to manufacture pharmaceutical drugs in future.